Torrent Pharmaceuticals Ltd

Torrent Pharma. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Torrent Pharmaceuticals Ltd

₹ 1,540 -0.28%
29 Mar - close price
torrentpharma.com BSE: 500420 NSE : TORNTPHARM
About

Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.[1]

It is the flagship company of Torrent Group which also has presence in power and city gas distribution businesses.[2]

Key Points

Product Offerings
The company manufactures pharmaceutical products under various dosage forms such as oral solids, oral liquids, topicals, suppositories, Human insulin and synthetic APIs. API manufacturing is predominantly aimed at captive consumption.[1]

Website BSE NSE
  • Market Cap ₹ 52,117 Cr.
  • Current Price ₹ 1,540
  • High / Low ₹ 1,750 / 1,242
  • Stock P/E 42.2
  • Book Value ₹ 180
  • Dividend Yield 0.91 %
  • ROCE 18.9 %
  • ROE 18.3 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company has been maintaining a healthy dividend payout of 68.2%

Cons

  • Stock is trading at 8.55 times its book value
  • The company has delivered a poor sales growth of 7.91% over past five years.
  • Company might be capitalizing the interest cost
  • Working capital days have increased from 56.2 days to 88.9 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
1,966 1,946 2,056 2,017 1,995 1,937 2,134 2,137 2,108 2,131 2,347 2,291 2,491
1,426 1,398 1,395 1,382 1,388 1,355 1,457 1,477 1,570 1,570 1,635 1,612 1,767
Operating Profit 540 548 661 635 607 582 677 660 538 561 712 679 724
OPM % 27% 28% 32% 31% 30% 30% 32% 31% 26% 26% 30% 30% 29%
53 15 4 6 8 39 40 51 48 -429 30 16 -10
Interest 111 102 102 92 91 73 68 71 62 57 55 69 102
Depreciation 163 168 161 165 167 165 165 168 167 162 155 163 193
Profit before tax 319 293 402 384 357 383 484 472 357 -87 532 463 419
Tax % 21% -7% 20% 19% 17% 15% 32% 33% 30% -36% 33% 33% 32%
Net Profit 251 314 321 310 297 324 330 316 249 -118 354 312 283
EPS in Rs 7.42 9.28 9.49 9.16 8.78 9.57 9.75 9.34 7.36 -3.49 10.46 9.22 8.36
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
2,195 2,691 3,203 4,172 4,636 6,687 5,816 5,950 7,673 7,939 8,005 8,508 9,260
1,807 2,189 2,506 3,216 3,616 3,954 4,438 4,601 5,690 5,769 5,524 6,077 6,584
Operating Profit 389 502 697 955 1,020 2,733 1,377 1,349 1,983 2,170 2,480 2,431 2,676
OPM % 18% 19% 22% 23% 22% 41% 24% 23% 26% 27% 31% 29% 29%
55 -22 1 34 286 32 223 299 -300 121 57 -288 -393
Interest 39 39 34 59 175 184 206 308 504 451 353 255 283
Depreciation 63 82 83 87 191 238 307 409 618 654 658 662 673
Profit before tax 342 359 582 844 940 2,343 1,088 931 562 1,187 1,526 1,226 1,327
Tax % 21% 20% 25% 21% 20% 26% 14% 27% 22% 14% 18% 37%
Net Profit 270 286 435 664 751 1,733 934 678 436 1,025 1,252 777 831
EPS in Rs 7.98 8.39 12.79 19.62 22.19 51.22 27.59 20.04 12.89 30.28 36.99 22.97 24.55
Dividend Payout % 25% 25% 45% 25% 25% 34% 25% 35% 66% 53% 47% 105%
Compounded Sales Growth
10 Years: 12%
5 Years: 8%
3 Years: 4%
TTM: 11%
Compounded Profit Growth
10 Years: 13%
5 Years: 4%
3 Years: 22%
TTM: 1%
Stock Price CAGR
10 Years: 24%
5 Years: 20%
3 Years: 18%
1 Year: 10%
Return on Equity
10 Years: 24%
5 Years: 18%
3 Years: 21%
Last Year: 18%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
42 42 42 85 85 85 85 85 85 85 85 85 169
Reserves 980 1,152 1,380 1,818 2,406 3,409 4,266 4,538 4,640 4,739 5,753 5,868 5,922
572 579 693 1,132 2,740 2,352 2,510 6,462 6,038 5,784 4,874 4,070 4,083
941 1,275 1,638 1,988 2,589 3,040 2,740 3,159 3,351 3,402 3,363 2,884 3,045
Total Liabilities 2,536 3,048 3,753 5,022 7,820 8,886 9,601 14,243 14,113 14,010 14,075 12,906 13,219
636 797 820 875 2,833 2,859 3,688 7,855 7,748 7,533 7,065 6,423 6,499
CWIP 180 119 285 534 678 1,042 519 647 617 712 889 630 609
Investments 146 124 60 186 298 780 804 492 353 2 181 226 505
1,574 2,008 2,587 3,427 4,011 4,206 4,589 5,249 5,395 5,763 5,940 5,628 5,606
Total Assets 2,536 3,048 3,753 5,022 7,820 8,886 9,601 14,243 14,113 14,010 14,075 12,906 13,219

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
395 486 153 599 810 2,742 1,009 894 1,798 1,393 2,005 1,803
-233 -137 -247 -418 -2,113 -869 -798 -4,677 -246 229 -444 -196
-68 -193 20 86 1,212 -1,435 -193 3,417 -1,314 -1,549 -1,651 -1,781
Net Cash Flow 94 156 -73 268 -90 437 18 -366 238 73 -89 -174

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 57 71 78 96 125 79 60 77 68 76 69 70
Inventory Days 265 225 364 297 275 314 318 429 318 362 456 368
Days Payable 322 365 421 421 472 523 356 447 345 345 351 250
Cash Conversion Cycle -1 -69 22 -28 -71 -130 21 59 42 93 174 188
Working Capital Days -4 0 33 42 54 -1 28 20 -17 -2 82 89
ROCE % 25% 27% 33% 35% 27% 48% 19% 13% 13% 15% 17% 19%

Shareholding Pattern

Numbers in percentages

Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
71.25 71.25 71.25 71.25 71.25 71.25 71.25 71.25 71.25 71.25 71.25 71.25
9.82 10.99 12.17 11.96 11.37 11.65 11.53 11.63 10.88 10.80 11.37 12.09
10.86 9.71 8.44 8.09 8.35 8.42 8.72 8.94 9.74 10.01 9.40 8.77
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.10 0.10
8.08 8.05 8.14 8.70 9.03 8.68 8.50 8.18 8.14 7.95 7.87 7.78

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls